ArticleMetabolic brain disease2023

PERK inhibitor, GSK2606414, ameliorates neuropathological damage, memory and motor functional impairments in cerebral ischemia via PERK/p-eIF2ɑ/ATF4/CHOP signaling.

Neha Dhir et al.PubMed ↗Publisher ↗

No numbers read from the abstract.